Join the upcoming SPARK GLOBAL Webinar on Tuesday, February 10th, at 5:00 PM Pacific Time, by registering here.  

Dr. Jin Billy Li, a professor of Genetics at Stanford University, will share his experiences participating in the SPARK at Stanford program and the role it played in founding two companies. 

Dr. Jin Billy Li's research has focused on RNA editing mediated by ADAR enzymes from two distinct perspectives. First, he has co-developed methods to harness ADAR enzymes for RNA base editing, work that led him to co-found AIRNA, which has successfully raised $245 million in funding. Second, his laboratory has investigated the biological function of RNA editing in preventing RNA-mediated autoimmunity, forming the scientific basis for Mangrove Therapeutics. Both projects were initially supported by the SPARK Program at Stanford. Before establishing his laboratory at Stanford in 2010, Dr. Li completed his postdoctoral training at Harvard Medical School. He received his bachelor’s degree from Tsinghua University in Beijing, China, and his Ph.D. from Washington University in St. Louis.